ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,870,288 | -26.2% | 218,470 | -2.0% | 0.00% | -33.3% |
| Q2 2023 | $7,951,289 | +35.0% | 222,975 | -3.8% | 0.00% | +50.0% |
| Q1 2023 | $5,889,321 | -48.0% | 231,863 | -17.0% | 0.00% | -50.0% |
| Q4 2022 | $11,330,071 | +28.3% | 279,341 | +4.6% | 0.00% | +33.3% |
| Q3 2022 | $8,830,000 | -6.7% | 267,173 | -0.6% | 0.00% | 0.0% |
| Q2 2022 | $9,465,000 | -19.5% | 268,797 | +5.1% | 0.00% | -25.0% |
| Q1 2022 | $11,757,000 | -22.1% | 255,643 | +12.3% | 0.00% | -20.0% |
| Q4 2021 | $15,097,000 | +7.9% | 227,706 | +1.6% | 0.01% | 0.0% |
| Q3 2021 | $13,987,000 | -15.9% | 224,045 | +11.6% | 0.01% | -16.7% |
| Q2 2021 | $16,625,000 | -13.2% | 200,735 | -30.5% | 0.01% | -14.3% |
| Q1 2021 | $19,146,000 | -0.1% | 288,732 | +15.6% | 0.01% | -12.5% |
| Q4 2020 | $19,165,000 | +84.0% | 249,779 | +3.2% | 0.01% | +60.0% |
| Q3 2020 | $10,418,000 | -1.1% | 241,963 | -0.8% | 0.01% | 0.0% |
| Q2 2020 | $10,537,000 | +161.4% | 243,954 | +74.1% | 0.01% | +150.0% |
| Q1 2020 | $4,031,000 | -54.9% | 140,103 | -0.5% | 0.00% | -50.0% |
| Q4 2019 | $8,930,000 | +15.4% | 140,792 | -48.7% | 0.00% | 0.0% |
| Q3 2019 | $7,740,000 | +30.7% | 274,662 | +22.9% | 0.00% | +33.3% |
| Q2 2019 | $5,924,000 | +1722.8% | 223,503 | +1161.1% | 0.00% | – |
| Q1 2019 | $325,000 | +70.2% | 17,723 | +15.2% | 0.00% | – |
| Q4 2018 | $191,000 | -27.7% | 15,388 | +11.8% | 0.00% | – |
| Q3 2018 | $264,000 | +40.4% | 13,770 | 0.0% | 0.00% | – |
| Q2 2018 | $188,000 | +506.5% | 13,770 | -17.2% | 0.00% | – |
| Q1 2017 | $31,000 | -6.1% | 16,635 | -18.5% | 0.00% | – |
| Q4 2016 | $33,000 | -46.8% | 20,401 | +147.2% | 0.00% | – |
| Q3 2016 | $62,000 | +40.9% | 8,254 | 0.0% | 0.00% | – |
| Q2 2016 | $44,000 | – | 8,254 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |